Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small-cell lung cancer: a randomized trial - Kris, M G; Natale, R B; Herbst, R S (JAMA, 2003)